GLOB | Ticker Profile - Titan Protect

GLOB

Globant S.A.

Technology · Information Technology Services · NYQ

$38.30

Data: 2026-05-15

✗ ETHICAL FAIL

WEAK MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.5B

Total market value of the company

Trailing P/E

14.88

Reasonably valued

Forward P/E

5.12

Based on estimated future earnings — lower means cheaper

Rev Growth

-4.7%

Year-over-year revenue change

Profit Margin

4.2%

How much profit the company keeps from each dollar of revenue

ROE

5.0%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$67.30

+76% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 23 analysts covering this stock

About Globant S.A.

Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development lifecycle; GUT Studio, which allows clients to better connect brands to end-consumers through experiential marketing; and Enterprise Studio, which leverages tailored technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, enabling industry-specific fine-tuning, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows that operate across systems, teams, and physical environments. Further, it provides GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, for marketing, communications, and advertising, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. The company has a collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.

https://www.globant.com

Country: Luxembourg Employees: 28,773 Industry: Information Technology Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

35.6% FAIL

Debt must be below 33% of total assets

Cash Ratio

17.0% PASS

Interest-bearing cash below 33% of assets

Receivables

0.0% PASS

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Valuation

Fair Value Est.

$99.91

What our model estimates this business is worth per share

Margin of Safety

61.7%

Deep discount to fair value — significant undervaluation

Rating

AVOID

Overall assessment combining ethics, valuation, and quality

Percentile

38.4th

Ranks in the top 62% of our 13,571 screened universe

Ethical Score

10.0

Valuation Score

95.0

Quality Score

33.3

Combined

N/A

Trading at $34 against a fair value of $100, a 66% discount. Fails ethical screen (Debt ratio). Ranks better than 72% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

-1.041

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.1084

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.603

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-52.0%

Historical annualised return based on price data

Max Drawdown

-86.2%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.04

Moves slightly more than the broader market

52W High

$107.12

64% below the year high

52W Low

$32.50

18% above the year low

Avg Volume

1,491,101

Average daily shares traded — higher means easier to buy and sell

Short Ratio

5.4

Days it would take all short sellers to cover — higher means more crowded

Short % Float

16.0%

Elevated short interest — bears are positioned against this

Div Yield

0.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$2.29

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

0.24

Conservative use of debt — low financial risk

Current Ratio

1.64

Healthy liquidity position

Quick Ratio

1.55

Like current ratio but excludes inventory — stricter test

Gross Margin

35.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

19.1%

Profit from core operations before interest and tax

Free Cash Flow

$292M

Positive — the business generates more cash than it spends

Revenue (TTM)

$2.5B

Total revenue over the last 12 months

Net Income

$103M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$120.00

Target Median

$67.30

Target Low

$44.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
2026-04-24	Ro Khanna	Democrat	Purchase	1K–15K
2026-04-20	Richard Blumenthal	Democrat	Sale	15K–50K
2026-04-13	Ro Khanna	Democrat	Purchase	1K–15K
2026-04-13	Ro Khanna	Democrat	Sale	1K–15K
2026-04-13	Ro Khanna	Democrat	Sale	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Before you go